Nutritional Outlook Quotes Partner Kristi Wolff on the Future Status of CBD
July 6, 2018
Partner Kristi Wolff was mentioned in the Nutritional Outlook article, “Does FDA’s Epidiolex CBD Drug Approval Threaten Legal Status of CBD Supplements?” In June, FDA approved Epidiolex, the first drug made of cannabidiol (CBD). The legal status of CBDs, which are a derivative of the hemp plant, has been widely argued, with particular attention to its use as a dietary supplement ingredient. Kristi tackles the question of whether the Epidiolex approval will affect the future status of CBD as a dietary supplement ingredient, stating that it “will impact the existing arguments for legality of hemp-derived CBD, which focus on the long history of hemp being used for a variety of products in the U.S.”

To read the full article, please click here.